Table 4.
Antidiabetic activity of single dose crude extract on streptozotocin-induced diabetic mice.
| Group mg/kg | BGL (mg/dl) | % BGL reduction | ||||
|---|---|---|---|---|---|---|
| 0 (h) | 1 (h) | 2 (h) | 4 (h) | 6 (h) | 0 (h) to 6 (h) | |
| NC | 99.20 ± 1.97 | 96.00 ± 1.73 | 91.20 ± 1.62 | 95.2 ± 7.39 | 95.00 ± 3.31 | 4.2 |
| DC | 325.50 ± 1.25 | 332.50 ± 2.14 | 330.83 ± 2.64 | 337.00 ± 3.60 | 338.67 ± 1.80 | -4.00 |
| RA 100 | 324.10 ± 2.23 | 273.50 ± 1.45a1b3 | 242.00 ± 1.73a2b3 | 228.00 ± 4.21a3b3 | 216.33 ± 3.43a3b3 | 33.25 |
| RA 200 | 325.00 ± 1.15 | 245.60 ± 1.30a2b3 | 215.60 ± 1.30a2b3 | 205.50 ± 1.26a3b3c2 | 194.50 ± 1.31a3b3c3 | 40.15 |
| RA 400 | 326.60 ± 2.39 | 247.40 ± 1.70a2b3c3 | 199.40 ± .70a2b3c3d | 178.83 ± 0.60a3b3c3d3 | 158.50 ± .96a3b3c3d3 | 51.72 |
| GLC 5 | 325.80 ± 1.40 | 192.00 ± 1.15a3b3c3d3 | 165.80 ± 1.40a3b3c3d3 | 141.00 ± 1.91a3b3c3d3 | 124.83 ± 1.56a3b3c3d3 | 61.68 |